EN / CN

News

Current Position: Home ››  News

23

2026Year07Month

Good News | Amlodipine Besylate API Officially Approved for Marketing!

Good News | Amlodipine Besylate API Officially Approved for Marketing!
[View Details]

19

2026Year07Month

Set Benchmarks · Embark Anew | Newland Pharma Amoeba Management Phase I Commendation & Training Conference Concludes Successfully

On July 18, Xintiandi Pharma held the Phase I commendation and training activity for the Amoeba Management Project in the multi-functional lecture hall on the third floor of the company. The event was attended by the company’s middle and senior management personnel, all Amoeba leaders, and senior consultants from Bomington Consulting. Centering on phased work summary, outstanding employee recognit
[View Details]

06

2026Year07Month

Meeting in Bangkok, Jointly Forge a New Landscape for Pharmaceuticals Newland Pharma Invites You to CPHI Southeast Asia

Meeting in Bangkok, Jointly Forge a New Landscape for Pharmaceuticals Newland Pharma Invites You to CPHI Southeast Asia
[View Details]

23

2026Year06Month

Good News | Levamlodipine Besylate API Approved!

Good News | Levamlodipine Besylate API Approved!
[View Details]

23

2026Year06Month

Good News: Levamlodipine Besylate API Obtains Approval

Good News: Levamlodipine Besylate API Obtains Approval
[View Details]
Total54Items   1 / 11Page  Per Page5Items  First Page  Previous  Next  Last Page